Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus.

Bibliographic Details
Title: Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus.
Authors: Shaikh, M. Guftar, Lucas-Herald, Angela K., Dastamani, Antonia, Estebanez, Maria Salomon, Senniappan, Senthil, Abid, Noina, Ahmad, Sumera, Alexander, Sophie, Avatapalle, Bindu, Awan, Neelam, Blair, Hester, Boyle, Roisin, Chesover, Alexander, Cochrane, Barbara, Craigie, Ross, Cunjamalay, Annaruby, Dearman, Sarah, De Coppi, Paolo, Erlandson-Parry, Karen, Flanagan, Sarah E.
Source: Frontiers in Endocrinology; 2023, p1-16, 16p
Subject Terms: HYPERINSULINISM, HYPOGLYCEMIA, INSULIN, WATERSHED management, ETIOLOGY of diseases, AGENESIS of corpus callosum, BEST practices
Geographic Terms: UNITED Kingdom
Abstract: Congenital hyperinsulinism (CHI) is a condition characterised by severe and recurrent hypoglycaemia in infants and young children caused by inappropriate insulin over-secretion. CHI is of heterogeneous aetiology with a significant genetic component and is often unresponsive to standard medical therapy options. The treatment of CHI can be multifaceted and complex, requiring multidisciplinary input. It is important to manage hypoglycaemia in CHI promptly as the risk of long-term neurodisability arising from neuroglycopaenia is high. The UK CHI consensus on the practice and management of CHI was developed to optimise and harmonise clinical management of patients in centres specialising in CHI as well as in non-specialist centres engaged in collaborative, networked models of care. Using current best practice and a consensus approach, it provides guidance and practical advice in the domains of diagnosis, clinical assessment and treatment to mitigate hypoglycaemia risk and improve long term outcomes for health and well-being. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Endocrinology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:16642392
DOI:10.3389/fendo.2023.1231043
Published in:Frontiers in Endocrinology
Language:English